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The Opioid Epidemic
• 130 people die of opioid overdose every day in the U.S.
• 2.2 million children affected (through 2017)
• $117.5 billion in costs during childhood
• By 2030: 4.3 million children and $400 billion
CDC, 2018; Brundage et al., 2019
CDC, 2018
The Opioid Epidemic
• Federal funds to Alaska in 2015
• Alaska public health disaster declaration in Feb 2017




















1. Centers for Disease Control and Prevention; National Center for Health Statistics. *2018 data preliminary
2. Alaska Division of Public Health; Health Analytics and Vital Records. 
Data Sources
• Primary
• Key informant interviews










• Partnerships and coordination
• Policies, practices, and laws
• Data and data monitoring
• Knowledge and readiness
• SWOT analysis
Findings related to policy:
• Strengths
• PDMP reporting and timeliness 
improvements
• Medicaid expansion
• Good Samaritan laws
• Access to naloxone
SB 74, which was our omnibus 
Medicaid Reform Bill, [and it] included 
all the recommendations of the 
controlled substances advisory 
committee to strengthen the 
Prescription Drug Monitoring Program
So, the Medicaid reform, as well as 
Medicaid expansion, will help expand 
access to treatment for people who 
are ‘recovery ready,’ as we say.
Findings related to policy:
• Strengths
• PDMP reporting and timeliness 
improvements
• Medicaid expansion
• Good Samaritan laws
• Access to naloxone
• Weaknesses
• Limited access to PDMP
• Criminal justice approach
• Opportunities
• PDMP unsolicited reporting
• Statewide prescribing guidelines
• Expand immunity laws
Timeline of relevant policy changes: 
• Feb 2017 – disaster declaration
• Standing order for naloxone
• January 2017 – Opioid prescribing
• Adopted guidelines
• July 2017 – PDMP responsibilities
• Providers/dispensers: registration, 
delegates, recording, and checking
• Board of Pharmacy: unsolicited 
reports to providers/dispensers, 
reporting to legislature
• July 2017 – Opioid prescribing
• Limits and sanctions
• 7-day maximum supply
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All Opioid, Prescription Opioid, & Heroin Poisoning 
Discharges (HFDR)
All Opioids Rx Opioids Heroin
The Challenge
• Identifying specific influence of policies
• Informing future policy development
• Next steps: 
• Follow-up key informant interviews
• Continued monitoring of secondary data
Thank you! 
Questions?
BLHanson4@alaska.edu
